Top Asthma Articles for July 2012

Here are my suggestions for some of the top articles about asthma for July 2012:

Wheezing disorders in preschool children: an evidence-based approach (free full text, ERJ 2012) http://bit.ly/LAKlDq

GSK once-daily lung drug LAMA/LABA (umeclidinium/vilanterol) showed positive results in COPD http://goo.gl/s1o0P

According to the U.S. government, GSK used illegal marketing tactics to promote Advair off-label for mild asthma - WSJ http://goo.gl/Kj2oW

Eating peanut/tree nuts during pregnancy may decrease asthma and rhinitis in children - Danish Birth Cohort study http://goo.gl/jfaZM

Influence of dentures in the mouths of elderly astmatics: 3 times gargling after inhaling ICSs is required http://goo.gl/nsGF6

Relying on the symptom of wheeze to diagnose asthma in children may be an important cause of undertreatment (study) http://goo.gl/SzZdC

Low Serum Adiponectin Predicts Future Risk for Asthma in Women http://goo.gl/gnQFs

Exhaled eicosanoids could help to diagnose and monitor childhood asthma http://bit.ly/POqjWq

Vitamin D insufficiency is associated with asthma exacerbations independently of race, atopy, or markers of control http://goo.gl/yvXqQ

Aclidinium bromide (Tudorza Pressair) is approved for long-term treatment of bronchospasm associated with COPD http://buff.ly/LKC5ef

Poor air quality in classrooms related to asthma and rhinitis in primary schoolchildren http://goo.gl/0AXmG

Sputum inflammatory phenotypes are not stable in children with asthma http://goo.gl/tYqk6

Allergy, living and learning: diagnosis and treatment of allergic respiratory diseases in Europe http://1.usa.gov/QGLA4R

The articles were selected from my Twitter stream @Allergy and Google Reader RSS subscriptions. Some of the top allergy accounts on Twitter contributed links. I appreciate the curation provided by @JuanCIvancevich @AllergyNet @IgECPD4 @DrAnneEllis @AACMaven @AllergieVoeding @allergistmommy @mrathkopf @wheezemd. Please feel free to send suggestions for articles to allergycases@gmail.com and you will receive acknowledgement in the next edition of this publication.

No comments:

Post a Comment